Invesco Ltd. Voyager Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 22,527 shares of VYGR stock, worth $120,068. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,527

Previous 131,963 82.93%

Holding current value

$120,068

Previous $1.04 Million 87.44%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$5.77 - $9.27 $631,445 - $1.01 Million	-109,436 Reduced 82.93%	22,527 $131,000
Q2 2024 Aug 13, 2024	BUY	$7.42 - $10.54 $822,929 - $1.17 Million	110,907 Added 526.72%	131,963 $1.04 Million
Q1 2024 May 14, 2024	BUY	$7.15 - $10.84 $13,241 - $20,075	1,852 Added 9.64%	21,056 $196,000
Q4 2023 Feb 12, 2024	SELL	$6.28 - $8.81 $96,730 - $135,700	-15,403 Reduced 44.51%	19,204 $162,000
Q3 2023 Nov 13, 2023	SELL	$7.55 - $11.25 $1.26 Million - $1.87 Million	-166,465 Reduced 82.79%	34,607 $268,000
Q2 2023 Aug 11, 2023	BUY	$6.94 - $13.99 $1.4 Million - $2.81 Million	201,072 New	201,072 $2.3 Million
Q4 2020 Feb 16, 2021	SELL	$7.15 - $12.28 $428,599 - $736,112	-59,944 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.01 - $13.75 $530 - $728	53 Added 0.09%	59,944 $639,000
Q2 2020 Aug 14, 2020	SELL	$8.05 - $14.21 $194,938 - $344,109	-24,216 Reduced 28.79%	59,891 $756,000
Q1 2020 May 15, 2020	BUY	$6.8 - $14.66 $30,620 - $66,013	4,503 Added 5.66%	84,107 $770,000
Q4 2019 Feb 14, 2020	SELL	$12.82 - $16.85 $4.02 Million - $5.29 Million	-313,951 Reduced 79.77%	79,604 $1.11 Million
Q3 2019 Nov 14, 2019	SELL	$16.31 - $28.29 $450,155 - $780,804	-27,600 Reduced 6.55%	393,555 $6.77 Million
Q2 2019 Aug 14, 2019	BUY	$19.18 - $27.88 $6.99 Million - $10.2 Million	364,516 Added 643.58%	421,155 $11.5 Million
Q1 2019 May 15, 2019	SELL	$8.0 - $19.66 $322,160 - $791,708	-40,270 Reduced 41.55%	56,639 $1.08 Million
Q4 2018 Feb 14, 2019	BUY	$8.59 - $18.05 $832,448 - $1.75 Million	96,909 New	96,909 $911,000

Others Institutions Holding VYGR

# of Institutions

129

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $206M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account